MichaelJTroychakMD

PubMed

• Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy.
  Murphy, G. P., Elgamal, A. A., Troychak, M. J., Kenny, G. M.> ;Prostate. 2000 Mar 1
• Follow-up evaluation of a phase II prostate cancer vaccine trial.
  Tjoa, B. A., Simmons, S. J., Elgamal, A., Rogers, M., Ragde, H., Kenny, G. M., Troychak, M. J., Boynton, A. L., Murphy, G. P.> ;Prostate. 1999 Jul 1
• GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial.
  Simmons, S. J., Tjoa, B. A., Rogers, M., Elgamal, A., Kenny, G. M., Ragde, H., Troychak, M. J., Boynton, A. L., Murphy, G. P.> ;Prostate. 1999 Jun 1
• Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment.
  Murphy, G. P., Tjoa, B. A., Simmons, S. J., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Troychak, M. J., Salgaller, M. L., Boynton, A. L.> ;Prostate. 1999 Apr 1
• Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with h...
  Murphy, G. P., Tjoa, B. A., Simmons, S. J., Jarisch, J., Bowes, V. A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Cobb, O. E., Ireton, R. C., Troychak, M. J., S...> ;Prostate. 1999 Jan 1
• ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.
  Elgamal, A. A., Troychak, M. J., Murphy, G. P.> ;Prostate. 1998 Dec 1
• Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides.
  Tjoa, B. A., Simmons, S. J., Bowes, V. A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Cobb, O. E., Ireton, R. C., Troychak, M. J., Salgaller, M. L., Boynton, A....> ;Prostate. 1998 Jun 15
• Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients.
  Murphy, G. P., Maguire, R. T., Rogers, B., Partin, A. W., Nelp, W. B., Troychak, M. J., Ragde, H., Kenny, G. M., Barren, R. J., Bowes, V. A., Gregorakis, A. K., Holmes...> ;Prostate. 1997 Dec 1
• Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
  Murphy, G. P., Troychak, M. J., Cobb, O. E., Bowes, V. A., Kenny, R. J., Barren, R. J., Kenny, G. M., Ragde, H., Holmes, E. H., Wolfert, R. L.> ;Prostate. 1997 Oct 1
• Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides.
  Tjoa, B. A., Erickson, S. J., Bowes, V. A., Ragde, H., Kenny, G. M., Cobb, O. E., Ireton, R. C., Troychak, M. J., Boynton, A. L., Murphy, G. P.> ;Prostate. 1997 Sep 1
• Join now to see all